About john.davis

This author has not yet filled in any details.
So far john.davis has created 17 blog entries.

Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards

STONY BROOK, N.Y., November 25, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”) or (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced that it has received notification from Nasdaq that the Company has regained compliance with Nasdaq’s minimum [...]

Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards2019-11-25T14:00:01-05:00

Successful DNA Tagging of Leather at one of the World’s Largest Tanneries

STONY BROOK, N.Y., November 12, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA,” “we,” “our” or the “Company””), a leader in large-scale Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the successful DNA tagging of leather at one of the world’s largest tanneries based in Asia. The work follows a successful research project [...]

Successful DNA Tagging of Leather at one of the World’s Largest Tanneries2019-11-21T10:25:18-05:00

Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors

STONY BROOK, N.Y., November 8, 2019 –  Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the appointment of Scott L. Anchin to its Board of Directors following the resignation of [...]

Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors2019-11-08T15:26:08-05:00

Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients

STONY BROOK, N.Y. – July 2, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today the signing of a five-year Agreement with Germany-based Montblanc-Simplo GMBH (“Montblanc”) for the provision of unique SigNature® DNA marks for individual [...]

Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients2019-07-01T14:19:40-04:00

TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China

Stony Brook, NY, May 15, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today that partner TheraCann International Benchmark Corporation (“TheraCann”), a leading full service international cannabis consultancy and technology firm, in conjunction CannAcubed Pte Ltd (CannAcubed), a pioneer in the China cannabis space with a focus on building the world’s [...]

TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China2019-05-14T20:51:46-04:00

Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum Signed Today to Protect American Consumers and Industries

STONY BROOK N.Y., April 3, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced its recognition of and alignment with the Memorandum signed today by President Donald Trump to help protect American consumers, manufacturers, and factory workers from counterfeiting. Link to Presidential Memorandum Applied DNA [...]

Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum Signed Today to Protect American Consumers and Industries2019-04-04T09:23:39-04:00

Applied DNA and American & Efird to Collaborate on New Anti-Counterfeiting Sewing Thread Platform

Brands and Manufacturers can be certain that their products are authentic STONY BROOK, N.Y., (February 27, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it is collaborating with American & Efird, (A&E), one of the world’s leading manufacturers and distributors of industrial and consumer sewing thread, embroidery thread, [...]

Applied DNA and American & Efird to Collaborate on New Anti-Counterfeiting Sewing Thread Platform2018-03-07T09:09:52-05:00

ACG signs MoU with Applied DNA Sciences to Enhance Capsule Authentication and Traceability Technology for Pharmaceutical and Nutraceutical Industry

Collaboration to help thwart counterfeits with molecular tagging of capsules STONY BROOK, N.Y., (February 26, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s proven SigNature® molecular tagging and authentication technologies to develop molecularly-tagged empty [...]

ACG signs MoU with Applied DNA Sciences to Enhance Capsule Authentication and Traceability Technology for Pharmaceutical and Nutraceutical Industry2018-04-27T12:58:02-04:00

Applied DNA Awarded Additional U.S. Patent on its fiberTyping® Cotton Genotyping Technology

New Patent Strengthens the Company’s Robust Cotton Genotyping and Traceability Patent Portfolio STONY BROOK, N.Y., (February 22, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), is pleased to announce the receipt of a Notice of Allowance for its U.S. Patent Application No. 14/191,947 (US 2014/0295423 A1) entitled Methods for Genetic [...]

Applied DNA Awarded Additional U.S. Patent on its fiberTyping® Cotton Genotyping Technology2018-02-21T20:50:03-05:00

Applied DNA Reports Fiscal First Quarter 2018 Financial Results

Company To Hold Conference Call and Webcast Today, Thursday, February 8, 2018 at 4:30 PM EST. 8 February 2018 STONY BROOK, N.Y. – February 8, 2018 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced financial results for the fiscal 2018 first quarter ended December 31, 2017. “We made significant progress [...]

Applied DNA Reports Fiscal First Quarter 2018 Financial Results2018-04-19T10:06:39-04:00